Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) FCF Margin (2016 - 2025)

OptimizeRx (OPRX) has disclosed FCF Margin for 16 consecutive years, with 22.09% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 2109.0% to 22.09% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 17.05% through Dec 2025, up 1186.0% year-over-year, with the annual reading at 17.05% for FY2025, 1186.0% up from the prior year.
  • FCF Margin hit 22.09% in Q4 2025 for OptimizeRx, up from 12.08% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 29.61% in Q1 2022 to a low of 24.53% in Q4 2023.
  • Historically, FCF Margin has averaged 6.75% across 5 years, with a median of 8.44% in 2024.
  • Biggest five-year swings in FCF Margin: surged 6416bps in 2021 and later crashed -3829bps in 2023.
  • Year by year, FCF Margin stood at 6.76% in 2021, then skyrocketed by 304bps to 13.76% in 2022, then plummeted by -278bps to 24.53% in 2023, then soared by 104bps to 0.99% in 2024, then surged by 2124bps to 22.09% in 2025.
  • Business Quant data shows FCF Margin for OPRX at 22.09% in Q4 2025, 12.08% in Q3 2025, and 15.59% in Q2 2025.